Showing 191-200 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Network for Pancreatic Organ Donors – nPOD | University of Florida | Mark Atkinson | Cures | 01-October-2023 to 30-September-2026 | $8.100.000,00 |
| Targeting the Autoimmune Germinal Center Axis in Type 1 Diabetes | Vanderbilt University Medical Center (VUMC) | Rachel Bonami | Cures | 01-September-2023 to 31-August-2025 | $600.000,00 |
| Autoimmune stem-like T cells in type 1 diabetes | Memorial Sloan-Kettering Cancer Center | Andrea Schietinger | Cures | 01-September-2023 to 31-August-2026 | $750.000,00 |
| Assessment of a Tolerogenic Nanoparticle in a Humanized Mouse Islet Transplantation Model | Northwestern University | Jacqueline Burke | Cures | 01-April-2024 to 31-March-2026 | $499.746,76 |
| Non-invasive immunoimaging of islet transplant rejection | Beckman Research Institute of the City of Hope | Fouad Kandeel | Cures | 01-June-2023 to 31-May-2026 | $750.000,00 |
| Immune tolerance technology for islet transplantation | Wayne State University | Zhiqiang Cao | Cures | 01-July-2023 to 30-June-2025 | $199.231,00 |
| Determining how NKG2D signaling drives autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-September-2023 to 31-August-2026 | $750.000,00 |
| mIL-2/CD25 fusion protein and BTK inhibitor combination therapy for T1D | University of Miami | Wasif Khan | Cures | 01-May-2023 to 30-April-2026 | $974.996,00 |
| Newly identified novel autoantibodies specific to β-cell surface ZnT8 antigen as an early biomarker in type 1 diabetes | Regents of the University of Colorado | Xiaofan Jia | Cures | 01-September-2023 to 28-February-2026 | $499.998,96 |
| Defining human T cell-myeloid cell interactions in the islets | Regents of the University of Colorado | Rachel Friedman | Cures | 01-March-2023 to 28-February-2026 | $110.000,00 |